Get started
YS Biopharma Co., Ltd.YS Biopharma Co., Ltd.YS Biopharma Co., Ltd.

YS Biopharma Co., Ltd.

No trades
See on Supercharts
Overview
Financials News Ideas Technicals

YS chart

Upcoming earnings

Next report date
Report period
Q4 2023
EPS estimate
−0.08USD
Revenue estimate
‪21.88 M‬USD

Key stats

Market capitalization
‪141.25 M‬USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
—
Net income (FY)
—
Revenue (FY)
—
Shares float
‪17.94 M‬
Beta (1Y)
2.60

About YS Biopharma Co., Ltd.

Sector
Health Technology
Industry
Biotechnology
CEO
Hui Shao
Website
ysbiopharm.com
Headquarters
Beijing
Founded
2020
FIGI
BBG00ZKXZ446
YS Biopharma Co. Ltd. engages in discovering, developing, manufacturing, and commercializing vaccines and therapeutic biologics for infectious diseases and cancer. It focuses on developing PIKA technology platform. It operates through the People's Republic of China and Other Countries or Regions. The company was founded by Yi Zhang on November 16, 2020 and is headquartered in Beijing, China.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of YS is 0.7357 USD — it has decreased by 1.91% in the past 24 hours. Watch YS Biopharma Co., Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange YS Biopharma Co., Ltd. stocks are traded under the ticker YS.
YS Biopharma Co., Ltd. is going to release the next earnings report on May 29, 2024. Keep track of upcoming events with our Earnings Calendar.
YS stock is 6.52% volatile and has beta coefficient of 2.60. Track YS Biopharma Co., Ltd. stock price on the chart and check out the list of the most volatile stocks — is YS Biopharma Co., Ltd. there?
Yes, you can track YS Biopharma Co., Ltd. financials in yearly and quarterly reports right on TradingView.
YS stock has fallen by 9.17% compared to the previous week, the month change is a 3.11% rise, over the last year YS Biopharma Co., Ltd. has showed a 52.54% decrease.
YS net income for the last quarter is ‪−11.31 M‬ USD, while the quarter before that showed ‪5.71 M‬ USD of net income which accounts for −298.31% change. Track more YS Biopharma Co., Ltd. financial stats to get the full picture.
Today YS Biopharma Co., Ltd. has the market capitalization of ‪141.25 M‬, it has decreased by 13.21% over the last week.
No, YS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, YS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade YS Biopharma Co., Ltd. stock right from TradingView charts — choose your broker and connect to your account.
YS reached its all-time high on Mar 15, 2023 with the price of 18.4399 USD, and its all-time low was 0.3503 USD and was reached on Feb 2, 2024. View more price dynamics on YS chart.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So YS Biopharma Co., Ltd. technincal analysis shows the neutral today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating YS Biopharma Co., Ltd. stock shows the sell signal. See more of YS Biopharma Co., Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.